ID   HPPD_HUMAN              Reviewed;         393 AA.
AC   P32754; A8K461; B3KQ63; Q13234;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 175.
DE   RecName: Full=4-hydroxyphenylpyruvate dioxygenase;
DE            EC=1.13.11.27;
DE   AltName: Full=4-hydroxyphenylpyruvic acid oxidase;
DE            Short=4HPPD;
DE            Short=HPD;
DE            Short=HPPDase;
GN   Name=HPD; Synonyms=PPD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=7851880; DOI=10.1006/geno.1994.1540;
RA   Awata H., Endo F., Matsuda I.;
RT   "Structure of the human 4-hydroxyphenylpyruvic acid dioxygenase gene
RT   (HPD).";
RL   Genomics 23:534-539(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8521727;
RA   Stenman G., Roijer E., Rueetschi U., Dellsen A., Rymo L.,
RA   Lindstedt S.;
RT   "Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase
RT   gene (HPD) to 12q24-->qter by fluorescence in situ hybridization.";
RL   Cytogenet. Cell Genet. 71:374-376(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=9325050; DOI=10.1006/geno.1997.4887;
RA   Ruetschi U., Rymo L., Lindstedt S.;
RT   "Human 4-hydroxyphenylpyruvate dioxygenase gene (HPD).";
RL   Genomics 44:292-299(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 8-393 IN COMPLEX WITH COBALT
RP   IONS.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human 4-hydroxyphenylpyruvate dioxygenase.";
RL   Submitted (SEP-2009) to the PDB data bank.
RN   [12]
RP   VARIANTS TYRSN3 CYS-160 AND MET-335, AND VARIANTS THR-33; PHE-267 AND
RP   LEU-340.
RX   PubMed=10942115; DOI=10.1007/s004390000307;
RA   Rueetschi U., Cerone R., Perez-Cerda C., Schiaffino M.C., Standing S.,
RA   Ugarte M., Holme E.;
RT   "Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in
RT   patients with tyrosinemia type III.";
RL   Hum. Genet. 106:654-662(2000).
RN   [13]
RP   VARIANT TYRSN3 VAL-268, AND VARIANT HAWK THR-33.
RX   PubMed=11073718; DOI=10.1006/mgme.2000.3085;
RA   Tomoeda K., Awata H., Matsuura T., Matsuda I., Ploechl E., Milovac T.,
RA   Boneh A., Scott C.R., Danks D.M., Endo F.;
RT   "Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are
RT   responsible for tyrosinemia type III and hawkinsinuria.";
RL   Mol. Genet. Metab. 71:506-510(2000).
CC   -!- FUNCTION: Key enzyme in the degradation of tyrosine.
CC   -!- CATALYTIC ACTIVITY: 4-hydroxyphenylpyruvate + O(2) = homogentisate
CC       + CO(2).
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000250};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000250};
CC   -!- PATHWAY: Amino-acid degradation; L-phenylalanine degradation;
CC       acetoacetate and fumarate from L-phenylalanine: step 3/6.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|Ref.11}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P32754-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P32754-2; Sequence=VSP_044302;
CC   -!- DISEASE: Tyrosinemia 3 (TYRSN3) [MIM:276710]: An inborn error of
CC       metabolism characterized by elevations of tyrosine in the blood
CC       and urine, seizures and mild mental retardation.
CC       {ECO:0000269|PubMed:10942115, ECO:0000269|PubMed:11073718}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Hawkinsinuria (HAWK) [MIM:140350]: An inborn error of
CC       tyrosine metabolism characterized by failure to thrive, persistent
CC       metabolic acidosis, fine and sparse hair, and excretion of the
CC       unusual cyclic amino acid metabolite, hawkinsin, in the urine.
CC       {ECO:0000269|PubMed:11073718}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the 4HPPD family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D31628; BAA06498.1; -; Genomic_DNA.
DR   EMBL; X72389; CAA51082.1; -; mRNA.
DR   EMBL; U29895; AAC73008.1; -; Genomic_DNA.
DR   EMBL; AK057510; BAG51925.1; -; mRNA.
DR   EMBL; AK290826; BAF83515.1; -; mRNA.
DR   EMBL; AC069503; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079360; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW98292.1; -; Genomic_DNA.
DR   EMBL; BC024287; AAH24287.1; -; mRNA.
DR   CCDS; CCDS53839.1; -. [P32754-2]
DR   CCDS; CCDS9224.1; -. [P32754-1]
DR   PIR; S32458; S32458.
DR   RefSeq; NP_001165464.1; NM_001171993.1. [P32754-2]
DR   RefSeq; NP_002141.1; NM_002150.2. [P32754-1]
DR   UniGene; Hs.2899; -.
DR   PDB; 3ISQ; X-ray; 1.75 A; A=8-393.
DR   PDB; 5EC3; X-ray; 2.10 A; A=1-393.
DR   PDBsum; 3ISQ; -.
DR   PDBsum; 5EC3; -.
DR   ProteinModelPortal; P32754; -.
DR   SMR; P32754; -.
DR   BioGrid; 109482; 6.
DR   IntAct; P32754; 4.
DR   STRING; 9606.ENSP00000289004; -.
DR   BindingDB; P32754; -.
DR   ChEMBL; CHEMBL1861; -.
DR   DrugBank; DB02850; (1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone.
DR   DrugBank; DB00348; Nitisinone.
DR   iPTMnet; P32754; -.
DR   PhosphoSitePlus; P32754; -.
DR   BioMuta; HPD; -.
DR   DMDM; 417144; -.
DR   MaxQB; P32754; -.
DR   PaxDb; P32754; -.
DR   PeptideAtlas; P32754; -.
DR   PRIDE; P32754; -.
DR   DNASU; 3242; -.
DR   Ensembl; ENST00000543163; ENSP00000441677; ENSG00000158104. [P32754-2]
DR   GeneID; 3242; -.
DR   KEGG; hsa:3242; -.
DR   UCSC; uc058ujk.1; human. [P32754-1]
DR   CTD; 3242; -.
DR   DisGeNET; 3242; -.
DR   GeneCards; HPD; -.
DR   HGNC; HGNC:5147; HPD.
DR   HPA; HPA038321; -.
DR   HPA; HPA038322; -.
DR   MalaCards; HPD; -.
DR   MIM; 140350; phenotype.
DR   MIM; 276710; phenotype.
DR   MIM; 609695; gene.
DR   neXtProt; NX_P32754; -.
DR   OpenTargets; ENSG00000158104; -.
DR   Orphanet; 2118; Hawkinsinuria.
DR   Orphanet; 69723; Tyrosinemia type 3.
DR   PharmGKB; PA29420; -.
DR   eggNOG; KOG0638; Eukaryota.
DR   eggNOG; COG3185; LUCA.
DR   GeneTree; ENSGT00530000063474; -.
DR   HOGENOM; HOG000188687; -.
DR   HOVERGEN; HBG005987; -.
DR   InParanoid; P32754; -.
DR   KO; K00457; -.
DR   PhylomeDB; P32754; -.
DR   BioCyc; MetaCyc:HS08267-MONOMER; -.
DR   BRENDA; 1.13.11.27; 2681.
DR   Reactome; R-HSA-71182; Phenylalanine and tyrosine catabolism.
DR   UniPathway; UPA00139; UER00362.
DR   ChiTaRS; HPD; human.
DR   EvolutionaryTrace; P32754; -.
DR   GenomeRNAi; 3242; -.
DR   PRO; PR:P32754; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000158104; -.
DR   CleanEx; HS_HPD; -.
DR   ExpressionAtlas; P32754; baseline and differential.
DR   Genevisible; P32754; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IBA:GO_Central.
DR   GO; GO:0003868; F:4-hydroxyphenylpyruvate dioxygenase activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome.
DR   GO; GO:0006572; P:tyrosine catabolic process; ISS:UniProtKB.
DR   Gene3D; 3.10.180.10; -; 2.
DR   InterPro; IPR005956; 4OHPhenylPyrv_dOase.
DR   InterPro; IPR029068; Glyas_Bleomycin-R_OHBP_Dase.
DR   InterPro; IPR004360; Glyas_Fos-R_dOase_dom.
DR   PANTHER; PTHR11959; PTHR11959; 1.
DR   Pfam; PF00903; Glyoxalase; 2.
DR   PIRSF; PIRSF009283; HPP_dOase; 1.
DR   SUPFAM; SSF54593; SSF54593; 1.
DR   TIGRFAMs; TIGR01263; 4HPPD; 1.
DR   PROSITE; PS51819; VOC; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Dioxygenase; Disease mutation; Iron; Mental retardation;
KW   Metal-binding; Oxidoreductase; Phenylalanine catabolism;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Tyrosine catabolism.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    393       4-hydroxyphenylpyruvate dioxygenase.
FT                                /FTId=PRO_0000088388.
FT   DOMAIN       18    149       VOC 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01163}.
FT   DOMAIN      180    338       VOC 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01163}.
FT   METAL       183    183       Iron. {ECO:0000305}.
FT   METAL       266    266       Iron. {ECO:0000305}.
FT   METAL       349    349       Iron. {ECO:0000305}.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     132    132       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P49429}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49429}.
FT   MOD_RES     250    250       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49429}.
FT   VAR_SEQ       1     39       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044302.
FT   VARIANT      33     33       A -> T (in two patients with
FT                                hawkinsinuria; dbSNP:rs1154510).
FT                                {ECO:0000269|PubMed:10942115,
FT                                ECO:0000269|PubMed:11073718}.
FT                                /FTId=VAR_015444.
FT   VARIANT     113    113       R -> Q (in dbSNP:rs11833399).
FT                                /FTId=VAR_048101.
FT   VARIANT     160    160       Y -> C (in TYRSN3; dbSNP:rs28934278).
FT                                {ECO:0000269|PubMed:10942115}.
FT                                /FTId=VAR_015445.
FT   VARIANT     267    267       I -> F. {ECO:0000269|PubMed:10942115}.
FT                                /FTId=VAR_015446.
FT   VARIANT     268    268       A -> V (in TYRSN3).
FT                                {ECO:0000269|PubMed:11073718}.
FT                                /FTId=VAR_015447.
FT   VARIANT     335    335       I -> M (in TYRSN3).
FT                                {ECO:0000269|PubMed:10942115}.
FT                                /FTId=VAR_015448.
FT   VARIANT     340    340       V -> L (in dbSNP:rs36023382).
FT                                {ECO:0000269|PubMed:10942115}.
FT                                /FTId=VAR_015449.
FT   CONFLICT    162    162       A -> P (in Ref. 3; AAC73008).
FT                                {ECO:0000305}.
FT   STRAND       15     25       {ECO:0000244|PDB:3ISQ}.
FT   HELIX        29     40       {ECO:0000244|PDB:3ISQ}.
FT   STRAND       43     49       {ECO:0000244|PDB:3ISQ}.
FT   HELIX        50     52       {ECO:0000244|PDB:3ISQ}.
FT   STRAND       56     64       {ECO:0000244|PDB:3ISQ}.
FT   STRAND       67     76       {ECO:0000244|PDB:3ISQ}.
FT   HELIX        80     89       {ECO:0000244|PDB:3ISQ}.
FT   STRAND       91    101       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       103    113       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      117    126       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      129    137       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      143    151       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      154    156       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       170    172       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      178    187       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       193    204       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      207    212       {ECO:0000244|PDB:3ISQ}.
FT   TURN        214    216       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      223    230       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      237    244       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       251    259       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      261    272       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       274    283       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       293    303       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       314    320       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      323    326       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      331    337       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      340    344       {ECO:0000244|PDB:3ISQ}.
FT   STRAND      347    355       {ECO:0000244|PDB:3ISQ}.
FT   HELIX       361    377       {ECO:0000244|PDB:3ISQ}.
SQ   SEQUENCE   393 AA;  44934 MW;  4314A16532C33A2F CRC64;
     MTTYSDKGAK PERGRFLHFH SVTFWVGNAK QAASFYCSKM GFEPLAYRGL ETGSREVVSH
     VIKQGKIVFV LSSALNPWNK EMGDHLVKHG DGVKDIAFEV EDCDYIVQKA RERGAKIMRE
     PWVEQDKFGK VKFAVLQTYG DTTHTLVEKM NYIGQFLPGY EAPAFMDPLL PKLPKCSLEM
     IDHIVGNQPD QEMVSASEWY LKNLQFHRFW SVDDTQVHTE YSSLRSIVVA NYEESIKMPI
     NEPAPGKKKS QIQEYVDYNG GAGVQHIALK TEDIITAIRH LRERGLEFLS VPSTYYKQLR
     EKLKTAKIKV KENIDALEEL KILVDYDEKG YLLQIFTKPV QDRPTLFLEV IQRHNHQGFG
     AGNFNSLFKA FEEEQNLRGN LTNMETNGVV PGM
//
